Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Mydriatic Hyperspectral Retinal Camera (MHRC-C1)

K-Number: K200254 · 2020-04-27

Decision Date2020-04-27
Product CodeHKI
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

Mydriatic Hyperspectral Retinal Camera (MHRC-C1) is a medical device manufactured by Optina Diagnostics. It received FDA 510(k) clearance on 2020-04-27 under approval number K200254. The device is classified under product code HKI. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Mydriatic Hyperspectral Retinal Camera (MHRC-C1)?

Mydriatic Hyperspectral Retinal Camera (MHRC-C1) is a medical device that received FDA 510(k) clearance on 2020-04-27. It is manufactured by Optina Diagnostics. The 510(k) number is K200254.

When was Mydriatic Hyperspectral Retinal Camera (MHRC-C1) approved by the FDA?

Mydriatic Hyperspectral Retinal Camera (MHRC-C1) received FDA 510(k) clearance on 2020-04-27, under approval number K200254.

What company makes Mydriatic Hyperspectral Retinal Camera (MHRC-C1)?

Mydriatic Hyperspectral Retinal Camera (MHRC-C1) is manufactured by Optina Diagnostics.

What is the FDA product code for Mydriatic Hyperspectral Retinal Camera (MHRC-C1)?

The FDA product code for Mydriatic Hyperspectral Retinal Camera (MHRC-C1) is HKI.

Related Clinical Trials

Related Devices (Code: HKI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.